|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread[R] for Chronic Hepatitis B in Key Asian Countries. |
|
|
Nov 24, 2009 |
796 |
| India : Ranbaxy announces WHO pre-qualification of product. |
|
|
Nov 17, 2009 |
152 |
| Brazil: Brazil to donate US$7.86 million Mozambique for antiretroviral factory. |
|
|
Nov 15, 2009 |
140 |
| Nutritional Supplements Delay the Progression of AIDS in HIV-Infected Patients not Receiving Antiretroviral Treatment According to the Harold Foster Foundation. |
|
|
Oct 30, 2009 |
498 |
| Russia: AIDS Healthcare Foundation to Join Three Respected Saint-Petersburg Partners in Innovative New HIV Testing and ARV Treatment Collaboration. |
|
|
Oct 27, 2009 |
723 |
| Highly active antiretroviral therapy too hard to swallow for HIV patients. |
|
|
Oct 26, 2009 |
396 |
| Merck Announces Third-Quarter 2009 Financial Results. |
|
|
Oct 22, 2009 |
3928 |
| Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis[TM] HIV Program at the AIDS Vaccine 2009 Conference. |
|
Conference news |
Oct 21, 2009 |
1053 |
| United States : FDA Advisory Committee Recommends Approval Of Pfizer's Selzentry For Use In Patients Starting HIV Therapy For The First Time. |
|
|
Oct 12, 2009 |
272 |
| United states : FDA Advisory Committee Recommends Approval of Pfizer s Selzentry for Use in Patients Starting HIV Therapy for the First Time. |
|
|
Oct 9, 2009 |
274 |
| United States : FDA Advisory Committee approves Selzentry tablets for use in patients starting HIV therapy. |
|
|
Oct 9, 2009 |
274 |
| FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time. |
|
|
Oct 8, 2009 |
943 |
| Reduced dose of d4T still effective. |
Alcorn, Keith |
Report |
Oct 1, 2009 |
495 |
| UGANDA: MPs pressure government for more AIDS funding. |
|
|
Oct 1, 2009 |
442 |
| Zacks Analyst Blog Highlights: Merck, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and Abbott Labs. |
|
|
Sep 18, 2009 |
725 |
| Zimbabwe: NAC buys US$1m worth of ARVs. |
|
|
Sep 15, 2009 |
457 |
| Merck's ISENTRESS[R] (raltegravir) Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naove Patients. |
|
|
Sep 13, 2009 |
8187 |
| Cheaper HIV, TB drugs. |
|
|
Sep 1, 2009 |
185 |
| Uganda: HIV/AIDS Prevention, Care and Treatment Funding Available for Uganda. |
|
|
Aug 13, 2009 |
500 |
| United States : Clinton Foundation Reaches Deal With Matrix, Pfizer To Cut Prices For Second-Line ARVs, TB Drug. |
|
|
Aug 10, 2009 |
337 |
| United States : President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries. |
|
|
Aug 7, 2009 |
410 |
| New antiretroviral drug safe and effective for patients beginning HIV treatment. |
|
|
Aug 3, 2009 |
326 |
| Hypercoagulability due to protein S deficiency in HIV-seropositive patients. |
Orlovic, Dragana; Smego, Raymond A. |
Report |
Aug 1, 2009 |
2296 |
| 96-Week MERIT ES Analysis Shows Efficacy Of Pfizer's HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naove HIV Patients; Results Consistent With 48-Week Analysis. |
|
|
Jul 21, 2009 |
1249 |
| Merck Announces Second-Quarter 2009 Financial Results. |
|
|
Jul 21, 2009 |
3997 |
| Research and Markets: Forecast Insight Report: HIV - Cross-Class Fixed Dose Combinations Drive Continued Growth. |
|
|
Jul 20, 2009 |
365 |
| Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize New Fixed-Dose Combination of Truvada[R] and TMC278. |
|
|
Jul 16, 2009 |
744 |
| 'People are creating policy up there, they are not coming down': nurses' views on the expansion of routine provider-initiated HIV testing and counselling in Nairobi, Kenya. |
Evans, Catrin; Ndirangu, Eunice |
Report |
Jun 22, 2009 |
4416 |
| HIV nursing in Poland. |
Daniluk-Kula, Barbara |
Essay |
Jun 22, 2009 |
1221 |
| Research and Markets: Abacavir - Pipeline Selector. |
|
|
May 27, 2009 |
378 |
| Collaboration Agreement between Monogram and Pfizer Extended. |
|
|
May 18, 2009 |
880 |
| AIDS Patients with Serious Complications Benefit from Early Retroviral Use, Stanford Study Shows. |
|
Clinical report |
May 16, 2009 |
1202 |
| Gilead Sciences Files Second Patent Infringement Lawsuit Against Teva Pharmaceuticals. |
|
|
May 14, 2009 |
511 |
| Early antiretroviral therapy can reduce deaths in HIV patients. |
|
|
Apr 15, 2009 |
395 |
| Early antiretroviral therapy can reduce deaths in HIV patients by 28pct. |
|
|
Apr 10, 2009 |
395 |
| HIV patients need more nutritious food. |
|
|
Apr 10, 2009 |
219 |
| K'taka govt fails to address PLHA's concern: BHAF. |
|
|
Apr 9, 2009 |
589 |
| Gilead Sciences Announces Notification of ANDA Filing for Atripla[R]. |
|
|
Apr 6, 2009 |
536 |
| Free state--we can't pay for ARV needs. |
Bateman, Chris |
Brief article |
Apr 1, 2009 |
310 |
| Drug resistant HIV 'spreads between people without anti-retroviral treatment'. |
|
|
Mar 30, 2009 |
204 |
| Why the rush to take medication? Issues affecting when clients start medication. |
Brazington, Roy |
|
Mar 22, 2009 |
3130 |
| The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta. |
Sturtevant, Doris; Preiksaitis, Jutta; Singh, Ameeta; Houston, Stan; Gill, John; Predy, Gerry; Fishe |
Report |
Mar 1, 2009 |
4139 |
| Late treatment in Africa may disadvantage those with HIV for years. |
Alcorn, Keith; Safreed-Harmon, Kelly |
Report |
Mar 1, 2009 |
1160 |
| Tanzanians still suffer stigma of HIV, even with universal access to antiretrovirals. |
Owur, John |
Report |
Mar 1, 2009 |
832 |
| Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications? |
Ingiliz, P.; Benhamou, Y. |
Report |
Mar 1, 2009 |
4087 |
| Hepatitis B in HIV patients: what is the current treatment and what are the challenges? |
Soriano, Vincent; Tuma, Paula; Vispo, Eugenia; Labarga, Pablo; Fernandez, Jose Vicente; Medrano, Jos |
Report |
Mar 1, 2009 |
4761 |
| FDA Notifications. |
|
|
Mar 1, 2009 |
380 |
| Gilead Announces Data Demonstrating Pharmacokinetic Boosting Activity of GS 9350. |
|
|
Feb 9, 2009 |
2243 |
| Phase III Studies Showed ISENTRESS[R] in Combination Therapy Provided Significant Viral Load Reductions through 96 Weeks in Treatment-Experienced Patients with Triple-Class Resistant HIV. |
|
|
Feb 9, 2009 |
8751 |
| Data from ISENTRESS[R], Merck's HIV Integrase Inhibitor, in Patients Whose HIV is Controlled on a Lopinavir/Ritonavir-Based Therapy Presented at the 16th Conference on Retroviruses and Opportunistic Infections. |
|
Conference news |
Feb 9, 2009 |
8017 |
| Bioalliance Pharma Presents Results on a New Quinoline Family on HIV Integrase Inhibitors at the 16Th Conference on Retroviruses and Opportunistic Infections (CROI). |
|
Conference news |
Feb 6, 2009 |
587 |
| Merck Announces Fourth-Quarter and Full-Year 2008 Financial Results. |
|
|
Feb 3, 2009 |
4400 |
| Causes of death in HIV-infected persons who have tuberculosis, Thailand. |
Cain, Kevin P.; Anekthananon, Thanomsak; Burapat, Channawong; Akksilp, Somsak; Mankhatitham, Wiroj; |
Report |
Feb 1, 2009 |
6208 |
| The next condom conundrum: why use a rubber when you can just pop a pill? That's what HIV-negative guys across the country are asking themselves--and their doctors. As condom usage is down and HIV infection rates are up, could a prescription be the key to prevention? |
Weinstein, Steve |
|
Feb 1, 2009 |
1353 |
| Beating HIV. |
|
Brief article |
Feb 1, 2009 |
173 |
| Government's prison ARV obfuscation 'reprehensible'--Judge. |
Bateman, Chris |
|
Feb 1, 2009 |
445 |
| Children starting antiretrovirals in sub-Saharan Africa have a low risk of death. |
Farham, Bridget |
Report |
Jan 1, 2009 |
397 |
| Widespread resistance to antiretrovirals among children in the Central African Republic. |
Farham, Bridget |
Brief article |
Jan 1, 2009 |
328 |
| Gilead Sciences Files Patent Infringement Lawsuit Against Teva Pharmaceuticals. |
|
|
Dec 12, 2008 |
412 |
| Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS[R] (raltegravir) in Adult Patients Previously Untreated for HIV-1. |
|
|
Dec 12, 2008 |
7248 |
| Research and Markets: Independent Forecasts and Competitive Intelligence on Thailand's Pharmaceuticals and Healthcare Industry Q4 for 2008. |
|
|
Dec 10, 2008 |
533 |
| Merck Outlines Long-Term Prospects and Progress on Strategic Plan at 2008 Annual Business Briefing. |
|
|
Dec 9, 2008 |
2221 |
| Early testing, treatment dramatically prevents illness, death in HIV-positive babies. |
|
|
Dec 3, 2008 |
385 |
| With antiretroviral drugs, life, with HIV, goes on. |
Hollander, Dore |
Brief article |
Dec 1, 2008 |
263 |
| Pfizer's Novel HIV/AIDS Treatment SELZENTRY[TM] Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients. |
|
|
Nov 25, 2008 |
914 |
| Early testing, treatment dramatically prevents illness, death in HIV-positive babies. |
|
|
Nov 25, 2008 |
385 |
| High early mortality after starting antiretroviral treatment in Africa. |
|
Report |
Nov 1, 2008 |
621 |
| Uganda tests pill to prevent HIV infection. |
|
Brief article |
Nov 1, 2008 |
75 |
| Breastfeeding, antiretroviral prophylaxis and HIV. |
|
Brief article |
Nov 1, 2008 |
284 |
| New Phase III Study in Previously Untreated HIV Patients Showed Merck's ISENTRESS(R) (raltegravir) Reduced HIV Viral Load to Undetectable Levels, Comparable to Efavirenz, When Taken in Combination with Other Medicines. |
|
|
Oct 26, 2008 |
8191 |
| Pfizer's Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients. |
|
|
Oct 26, 2008 |
1010 |
| Merck Reports Third-Quarter 2008 Financial Results. |
|
Financial report |
Oct 22, 2008 |
4086 |
| Major Government Clinical Study Approved for Anadis' AIDS Therapy. |
|
|
Oct 21, 2008 |
563 |
| Mozambique: Anti-Retroviral Factory By 2010, Pledges Lula. |
|
|
Oct 20, 2008 |
556 |
| The best new aids drugs. |
|
Brief article |
Oct 7, 2008 |
55 |
| Zimbabwe: CAPS Seeks Funds For ARV Plant. |
|
|
Oct 4, 2008 |
311 |
| Reauthorization of U.S. global program on HIV/AIDS applauded. |
Krisberg, Kim |
|
Oct 1, 2008 |
1471 |
| ISENTRESS(TM) (raltegravir) Awarded Prix Galien USA Top Honor. |
|
|
Sep 25, 2008 |
478 |
| Advanced training course on ARV therapy for Central Asian experts held in Samarkand. |
|
|
Sep 10, 2008 |
328 |
| HIV and burns. |
Muganza, Adelin |
Clinical report |
Sep 1, 2008 |
1369 |
| Guidelines advise early antiretroviral Tx of HIV. |
Evans, Jeff |
|
Sep 1, 2008 |
982 |
| U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults. |
|
|
Aug 11, 2008 |
1560 |
| Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program with Start of a Phase IIb Trial in U.S. and Europe. |
|
|
Aug 5, 2008 |
747 |
| Experts say AIDS should be tackled earlier. |
|
|
Aug 4, 2008 |
527 |
| India: WHO approves another Ranabxy ARV drug. |
|
|
Aug 2, 2008 |
202 |
| Great strides made in universal access to HIV/AIDS treatments. |
Kohlway, Elizabeth |
|
Aug 1, 2008 |
686 |
| Getting fair treatment: Brazil faces new challenge in its fight against Big Pharma. |
Lateu, Jo |
|
Aug 1, 2008 |
614 |
| Body composition can provide valuable information in the management of women with HIV. |
Myburgh, Kathryn H.; De Bruto, Petro C. |
Report |
Jul 1, 2008 |
3940 |
| Dual drug class resistance in two-thirds of those failing antiretroviral therapy in South Africa. |
Farham, Bridget |
Report |
Jul 1, 2008 |
581 |
| There are many clinically important interactions between HIV and malaria. |
Cohen, Cheryl |
Report |
Jun 1, 2008 |
2746 |
| Monitor patients before treatment to improve survival in HIV. |
Farham, Bridget |
Report |
Apr 1, 2008 |
691 |
| Health services given boost to combat AIDS. |
Bateman, Chris |
Brief article |
Apr 1, 2008 |
168 |
| Controversies in current treatment guidelines. |
Gazzard, Brian G. |
Editorial |
Mar 1, 2008 |
2110 |
| Nucleoside analogues in 2008. |
Warwick, Zoe; Churchill, Duncan |
|
Mar 1, 2008 |
6113 |
| Metabolic effects of a growth hormone-releasing factor in patients with HIV. |
Kaul, Rupert |
Report |
Mar 1, 2008 |
386 |
| Carbamazepine-Indinavir Interaction Causes Antiretroviral Therapy Failure. |
|
|
May 1, 2000 |
483 |
| CDC creates two drug regimens to combat exposure to HI. |
|
|
Jul 1, 1998 |
2345 |
| Explaining postexposure prophylaxis to HCWs. |
|
|
Jul 1, 1998 |
199 |
| EHPs assess new CDC recommendations. |
|
|
Aug 1, 1996 |
1808 |
| Careful planning critical to developing postexposure policies. |
|
|
May 1, 1996 |
2699 |
|
